Vyjayanthi Krishnan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vyjayanthi krishnan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vyjayanthi Krishnan Today - Breaking & Trending Today

Altimmune Expands AdCOVID™ Manufacturing Collaboration With Lonza · BioBuzz

Altimmune Expands AdCOVID™ Manufacturing Collaboration With Lonza · BioBuzz
biobuzz.io - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biobuzz.io Daily Mail and Mail on Sunday newspapers.

United States , Martina Ribar Hestericov , Dirk Oehlers , Alberto Santagostino , Vipink Garg , Vyjayanthi Krishnan , Stacey Jurchison , Lonza Group Ltd , Altimmune Inc , Swiss Exchange , University Of Alabama At Birmingham , Exchange Commission , Singapore Exchange Securities Trading , Product Development For Altimmune , Dedicated Suite , Commercial Supply , Vice President , Product Development , Rgene Technologies , Chief Executive Officer , Swiss Alps , Looking Statement , Private Securities Litigation Reform Act , Media Contacts , Group Ltd , Singapore Exchange Securities Trading Limited ,

Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza

Published: Mar 12, 2021
Lonza to Commission a Dedicated Suite for Clinical and Commercial Supply of Altimmune’s COVID-19 Vaccine Candidate at its Houston Facility
GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2021 (GLOBE NEWSWIRE)
Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has expanded its previously-announced AdCOVID manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated manufacturing suite for clinical and commercial production of AdCOVID, Altimmune’s single-dose intranasal vaccine candidate for COVID-19, at its facility near Houston, Texas.
“Manufacturing capacity for COVID-19 vaccines has been severely constrained, and this limitation has presented considerable challenges for vaccine developers,” said Dr. Vyjayanthi Krishnan, Ph.D., Vice President of Product Development for Altimmune. “By expanding our Lonza collaboration and commissi ....

United States , Martina Ribar Hestericov , Dirk Oehlers , Alberto Santagostino , Vipink Garg , Vyjayanthi Krishnan , Stacey Jurchison , Head Of External Communications , Lonza Group Ltd , Altimmune Inc , Swiss Exchange , University Of Alabama At Birmingham , Exchange Commission , Singapore Exchange Securities Trading Limited , Product Development For Altimmune , Dedicated Suite , Commercial Supply , Vice President , Product Development , Rgene Technologies , Chief Executive Officer , Swiss Alps , Looking Statement , Private Securities Litigation Reform Act , Media Contacts , Group Ltd ,

Altimmune Extends Lonza Partnership To Support Production Of AdCOVID

Altimmune Extends Lonza Partnership To Support Production Of AdCOVID
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Biopharmaceutical Company , Commercial Production , Vyjayanthi Krishnan , வணிகரீதியானது ப்ரொடக்ஶந் , விஜயந்தி கிருஷ்ணன் ,

Lonza to commission Houston suite to supply Altimmune's COVID-19 vaccine candidate

FILE PHOTO: Logo of Swiss contract drug maker Lonza is seen in Basel
ZURICH (Reuters) – Lonza will commission a dedicated suite at its Houston viral vectors factory for clinical and commercial supply of U.S.-based Altimmune’s COVID-19 vaccine candidate, the Swiss contract drug manufacturer said on Friday.
Altimmune is developing a COVID-19 vaccine candidate to be administered via nasal spray, and has begun Phase 1 safety studies in humans, with expected data to come in the second quarter.
Lonza’s 300,000-square-foot cell and gene therapy factory, opened in 2018, will provide manufacturing space for Altimmune’s AdCOVID vaccine, which uses an adenovirus vector to help stimulate an immune response. The deal follows Lonza’s larger agreement with Moderna to produce drug substances for its mRNA vaccine in the United States and Switzerland. ....

United States , John Revill , Altimmune Ad , John Miller , Vyjayanthi Krishnan , ஒன்றுபட்டது மாநிலங்களில் , ஜான் மில்லர் , விஜயந்தி கிருஷ்ணன் ,

Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza

Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United States , Martina Ribar Hestericov , Dirk Oehlers , Alberto Santagostino , Vipink Garg , Vyjayanthi Krishnan , Stacey Jurchison , Head Of External Communications , Lonza Group Ltd , Altimmune Inc , Swiss Exchange , University Of Alabama At Birmingham , Exchange Commission , Singapore Exchange Securities Trading Limited , Product Development For Altimmune , Vice President , Product Development , Rgene Technologies , Chief Executive Officer , Swiss Alps , Looking Statement , Private Securities Litigation Reform Act , Media Contacts , Investor Relations , Group Ltd , Contact Details ,